Page 1 | Search Results | Cancer Immunology Research | American Association for Cancer Research

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Abstract PO023: Immune-mediated tumor growth inhibition by selective HDAC6 inhibitor SP-2-225

Scott Grindrod, Satish Noonepalle, Nima Aghdam, Alfredo Velena, Maria Gracia-Hernandez, Christian Zevallos-Delgado, Mira Jung, Anatoly Dritschilo, Alejandro Villagra

Cancer Immunol Res (2021) 9 (2_Supplement): PO023.

https://doi.org/10.1158/2326-6074.TUMIMM20-PO023

Published: 03 February 2021

View article titled, Abstract PO023: Immune-mediated tumor growth inhibition by selective HDAC6 inhibitor SP-2-225

Journal Articles

Abstract A066: Histone deacetylase 11 is an epigenetic regulator of T-cell pro-inflammatory function and novel target for enhancing T-cell anti-tumor activity

David M. Woods, Andressa L. Sodre, Karrune Woan, Alejandro Villagra, Amod Sarnaik, Jeffrey Weber, Eduardo M. Sotomayor

Cancer Immunol Res (2016) 4 (1_Supplement): A066.

https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A066

Published: 03 January 2016

View article titled, Abstract A066: Histone deacetylase 11 is an epigenetic regulator of T-cell pro-inflammatory function and novel target for enhancing T-cell anti-tumor activity

Journal Articles

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

David M. Woods, Andressa L. Sodré, Alejandro Villagra, Amod Sarnaik, Eduardo M. Sotomayor, Jeffrey Weber

Cancer Immunol Res (2015) 3 (12): 1375–1385.

https://doi.org/10.1158/2326-6066.CIR-15-0077-T

Published: 06 December 2015

View article titled, HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

Includes: Supplementary data

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract PO023: Immune-mediated tumor growth inhibition by selective HDAC6 inhibitor SP-2-225

Abstract A066: Histone deacetylase 11 is an epigenetic regulator of T-cell pro-inflammatory function and novel target for enhancing T-cell anti-tumor activity

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

Email alerts

AACR Journals

Resources

AACR Journals
on Social Media

Update search

Abstract PO023: Immune-mediated tumor growth inhibition by selective HDAC6 inhibitor SP-2-225

Abstract A066: Histone deacetylase 11 is an epigenetic regulator of T-cell pro-inflammatory function and novel target for enhancing T-cell anti-tumor activity

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

Email alerts

AACR Journals

Resources

AACR Journals on Social Media

This Feature Is Available To Subscribers Only

AACR Journals
on Social Media